Page 56 - ESHRE2019

Conclusion
Ethical Dilemmas on FSS decision are based on ...
Age of the patient (<40)
Years of Survival
Post Surgery and Chemotherapy – Ca survivors health condition Bilateral Oophorectomy increases the risk of CVD/CVA/osteoporosis Oocytes cryopreservation
Ovarian tissue cryopreservation
In cases with
Severe OTA – ART (spont. Cycles Vs ovulation induction) Concomitant health problems (Diabetes HBP etc)
References
Nam JH, Park JY. Fertility‐sparing surgery for young women with early‐stage epithelial ovarian cancer. Gynecol Obstet Invest 2013;76:14‐24.
Satoh T, Hatae M, Watanabe Y, Yaegashi N, Ishiko O, Kodama S, et al. Outcomes of fertility‐sparing surgery for stage I epithelial ovarian cancer: a proposal for patient selection. J Clin Oncol 2010;28:1727‐32.
Fruscio R, Corso S, Ceppi L, Garavaglia D, Garbi A, Floriani I, et al. Conservative management of early‐stage epithelial ovarian cancer: results of a large retrospective series. Ann Oncol 2013;24:138‐44.
National Cancer Institute (US). Joinpoint trend analysis software [Internet]. Bethesda, MD: National Cancer Institute; 2017 [cited 2017 Apr 17]. Available from: http://surveillance.cancer.gov/joinpoint.
Okamoto A, Glasspool RM, Mabuchi S, Matsumura N, Nomura H, Itamochi H, et al. Gynecologic Cancer InterGroup (GCIG) consensus review for clear cell carcinoma of the ovary. Int J Gynecol Cancer 2014;24:S20‐5.
Kajiyama H, Shibata K, Mizuno M, Hosono S, Kawai M, Nagasaka T, et al. Fertility‐sparing surgery in patients with clear‐cell carcinoma of the ovary: is it possible? Hum Reprod 2011;26:3297‐302.
Park JY, Suh DS, Kim JH, Kim YM, Kim YT, Nam JH. Outcomes of fertility‐sparing surgery among young women with FIGO stage I clear cell carcinoma of the ovary. Int J Gynaecol Obstet 2016;134:49‐52.
Nasioudis D, Chapman‐Davis E, Frey MK, Witkin SS, Holcomb K. Could fertility‐sparing surgery be considered for women with early stage ovarian clear cell carcinoma? J Gynecol Oncol 2017;28:e71.
Miyamoto M, Takano M, Goto T, Kato M, Sasaki N, Tsuda H, et al. Clear cell histology as a poor prognostic factor for advanced epithelial ovarian cancer: a single institutional case series through central pathologic review. J Gynecol Oncol 2013;24:37‐43.
54
51